Nanjing Noratech Pharmaceutical Co LTD

General

Total Cases3

Active Cases3

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/16/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024)
09/16/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	[SEALED] Joint Letter to The Honorable Richard G. Andrews, from Novartis and MSN, regarding bond pending appeal. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] McDuff Declaration, # [8] Chintapally Declaration, # [9] Certificate of Service) (Silver, Daniel) Modified on 9/16/2024 (nms). (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	NOTICE to Take Deposition of Jonathan W. Steed, Ph.D. on September 17, 2024 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	NOTICE to Take Deposition of Richard L. McCreery, Ph.D. on September 18, 2024 filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H)(Gattuso, Dominick) (Entered: 09/13/2024)
09/12/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	ORAL ORDER: A joint submission with a proposed order in follow up to The Federal Circuit's September 12, 2024, Order is due by the COB tomorrow (9/13/2024). To the extent the parties cannot agree, they should include arguments in support of their respective positions. Ordered by Judge Richard G. Andrews on 9/12/2024. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:22-cv-01395-RGA(nms) (Entered: 09/12/2024) ORAL ORDER: A joint submission with a proposed order in follow up to The Federal Circuit's September 12, 2024, Order is due by the COB tomorrow (9/13/2024). To the extent the parties cannot agree, they should include arguments in support of their respective positions. Ordered by Judge Richard G. Andrews on 9/12/2024. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:22-cv-01395-RGA(nms) (Entered: 09/12/2024)
09/12/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	ORDER of USCA as to [240] Notice of Appeal (Federal Circuit) filed by Novartis Pharmaceuticals Corporation. Decision of USCA: Upon consideration of the parties' responses to this court's August 22, 2024 order, IT IS ORDERED THAT: Appellants are directed to file a bond in the district court in an amount, and subject to terms and conditions, deemed appropriate by the district court.. (nms) (Entered: 09/12/2024) ORDER of USCA as to [240] Notice of Appeal (Federal Circuit) filed by Novartis Pharmaceuticals Corporation. Decision of USCA: Upon consideration of the parties' responses to this court's August 22, 2024 order, IT IS ORDERED THAT: Appellants are directed to file a bond in the district court in an amount, and subject to terms and conditions, deemed appropriate by the district court.. (nms) (Entered: 09/12/2024)
09/12/24	Novartis Pharmaceuticals Corp v. Nanjing Noratech Pharmaceutical Co Ltd 1:23-CV-00401 ( D. DE )	Pro Hac Vice Fee - Credit Card Payment received for Melinda R. Roberts and Shannon K. Clark. ( re [110] MOTION for Pro Hac Vice Appearance of Attorney Melinda R. Roberts and Shannon K. Clark )( Payment of $ 100, receipt number ADEDC-4496773).(Silver, Daniel) (Entered: 09/12/2024)
09/12/24	Novartis Pharmaceuticals Corp v. Nanjing Noratech Pharmaceutical Co Ltd 1:23-CV-00401 ( D. DE )	MOTION for Pro Hac Vice Appearance of Attorney Melinda R. Roberts and Shannon K. Clark - filed by Novartis Pharmaceuticals Corporation. (Attachments: # [1] Certifications for Melinda R. Roberts and Shannon K. Clark)(Silver, Daniel) (Entered: 09/12/2024)